Pan Masala Ad Proceedings Against SRK, Ajay Devgn, Tiger Shroff Complete Matter Up For Adjudication: Tukaram Mundhe
The FDA has concluded its investigation and found violations by the actors, he said, adding the matter will be referred for adjudication next week.
“Three actors sought time to respond. The assistant commissioner has completed the investigation and found that they violated the state's rules in the Vimal Pan Masala advertising case,” Mundhe told PTI.
“The proceedings have now concluded, and the case will be proposed for adjudication before the joint commissioner, who is the competent authority, by next week,” he added.
Also Read | Vimal Elaichi or surrogate ad? Why Maharashtra FDA flagged SRK, Ajay Devgn What is the case?The FDA had earlier issued notices to the three actors over their advertisements for Vimal Elaichi, alleging the campaign amounted to surrogate advertising for prohibited pan masala products.
The FDA had contended that the brand was linked to the sale of gutkha and pan masala, products prohibited in Maharashtra.
It had asked the actors to explain their association with the advertisements and take steps to discontinue the promotional campaigns.
The FDA had also warned them against further association with such advertisements and sought details of their due diligence before agreeing to endorse the product.
Also Read | HC rejects Vimal maker's plea on FDA notices to SRK, Ajay Devgn and Tiger Shroff What is an adjudication?Adjudication is a quasi-judicial process through which regulatory authorities examine evidence and determine violations of applicable laws. It allows penalties to be imposed for non-criminal offences without resorting to lengthy court proceedings.
Ajay Devgn moves Bombay HCBollywood actor Ajay Devgn has moved the Bombay High Court challenging a show-cause notice over his appearance in 'Vimal Elaichi' advertisements, calling the agency's action arbitrary.
A division bench of Chief Justice Mahesh Chandra Tripathi and Justice Advait Sethna is likely to hear Devgn's petition on November 4.
Devgn's petition stated that the notice was arbitrarily issued to him as an actor rather than to the manufacturing company.
Also Read | Tukaram Mundhe denies transfer reports, says he continues as Maha FDA chiefWhile Devgn has approached the High Court, the department would continue its proceedings before the joint commissioner, Mundhe said.
(With PTI inputs)
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment